Back
Incyte Vs. Biomarin Pharmaceutical Industry Stock Comparison
Buy
55
INCY
Incyte
Last Price:
75.89
Seasonality Move:
37.85%
Buy
56
BMRN
Biomarin Pharmaceutical
Last Price:
63.43
Seasonality Move:
13.04%
Buy
55
Incyte (INCY)
is a Buy
Is Incyte a Buy, Sell or Hold?
- The current Incyte [INCY] share price is $75.87. The Score for INCY is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- INCY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $63.42. The Score for BMRN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
INCY Stock Price Chart
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $63.42
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.
INCY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.42 | Buy |
| Relative Strength Index (14 RSI): | 55.55 | Buy |
| Chaikin Money Flow: | 509919 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66 - 79.28) | Buy |
| Bollinger Bands (100): | (60.65 - 71.63) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.75 | Sell |
| Relative Strength Index (14 RSI): | 26.27 | Sell |
| Chaikin Money Flow: | -1448636 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (65.93 - 70.21) | Sell |
| Bollinger Bands (100): | (69.5 - 87.66) | Sell |
INCY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 80.36 | Sell |
| 20-day SMA: | 74.29 | Buy |
| 50-day SMA: | 68.89 | Buy |
| 200-day SMA: | 61.74 | Buy |
| 8-day EMA: | 78.42 | Sell |
| 20-day EMA: | 75.46 | Buy |
| 50-day EMA: | 70.72 | Buy |
| 200-day EMA: | 64.37 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.04 | Sell |
| 20-day SMA: | 67.52 | Sell |
| 50-day SMA: | 70.73 | Sell |
| 200-day SMA: | 81.7 | Sell |
| 8-day EMA: | 65.78 | Sell |
| 20-day EMA: | 67.26 | Sell |
| 50-day EMA: | 71.26 | Sell |
| 200-day EMA: | 80.23 | Sell |
Incyte Earnings Growth & INCY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.29 per share, and an increase next year of $4.72 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.
Incyte Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||